STEREOSPECIFIC REDUCTION OF HALOPERIDOL IN HUMAN TISSUES

被引：42

作者：

EYLES, DW

POND, SM

机构：

[1] WOLSTON PK HOSP,CLIN STUDIES UNIT,BRISBANE,AUSTRALIA

[2] UNIV QUEENSLAND,PRINCESS ALEXANDRA HOSP,DEPT MED,BRISBANE,QLD 4000,AUSTRALIA

来源：

BIOCHEMICAL PHARMACOLOGY | 1992年 / 44卷 / 05期

关键词：

D O I：

10.1016/0006-2952(92)90117-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

In the current study, we have examined the catalytic activity and stereospecificity of haloperidol (HP) reductase activity in the cytosolic fractions of human brain' and liver and in whole blood. The reductase activity was NADPH-dependent and inhibited by menadione, features typical of the ketone reductases (EC 1.2.1). The V(max) in the brain was about 4-fold higher than in the liver. Moreover, the reaction was stereospecific in that only the S(-) enantiomer was detected in brain and blood and 99.2 +/- 0.1 % of the reduced HP (RHP) produced in the liver was S(-). The potential clinical implications of our results are unknown because until now all binding and pharmacodynamic studies with RHP have been performed with the racemate.

引用

页码：867 / 871

页数：5

共 20 条

[11] KORPI ER, 1985, ACTA PHARMACOL TOX, V56, P94
[12] INTERCONVERSIONS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN GUINEA-PIG AND RAT-LIVER MICROSOMES
KORPI, ER
COSTAKOS, DT
WYATT, RJ
[J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (16) : 2923 - 2927
[13] LOWRY OH, 1951, J BIOL CHEM, V193, P265
[14] MIDHA KK, 1987, J CLIN PSYCHOPHARM, V7, P362
[15] MIYAZAKI H, 1986, ARZNEIMITTEL-FORSCH, V36-1, P443
[16] Prelog V, 1964, PURE APPL CHEM, V9, P119
[17] STEREOSPECIFIC METABOLIC REDUCTION OF KETONES
PRELUSKY, DB
COUTTS, RT
PASUTTO, FM
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (12) : 1390 - 1393
[18] SMITH JN, 1954, BIOCHEM J, V57, P76
[19] WERMUTH B, 1985, ENZYMOLOGY CARBONYL, V2, P209
[20] WYSOWSKI DK, 1989, ARCH GEN PSYCHIAT, V46, P929

← 1 2 →